Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/20/17
End: 05/16/18
Due: 05/16/19
Phase: N/A
Priority: Normal
Start: 12/28/22
End: 03/21/24
Due: 03/21/25
Phase: N/A
Priority: Normal
Start: 03/13/18
End: 07/09/19
Due: 07/09/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| KP415 Classroom Study in Children (6-12 Years of Age) With ADHD | NCT03292952 | Zevra Therapeutics | user2@example.com | None | 2017-12-20 | 2018-05-16 | 2019-05-16 | - | - | 2025-07-14 |
| Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH | NCT05668754 | Zevra Therapeutics | user2@example.com | None | 2022-12-28 | 2024-03-21 | 2025-03-21 | - | - | 2025-07-14 |
| KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD | NCT03460652 | Zevra Therapeutics | user2@example.com | None | 2018-03-13 | 2019-07-09 | 2020-07-09 | - | - | 2025-07-14 |